One of the major obstacles in organ transplantation is to establish immune tolerance of allografts. While immunosuppressive drugs can prevent graft rejection to a certain degree, their efficacies are limited, transient, and associated with severe side effects. Induction of thymic central tolerance to allografts remains challenging, largely due to the difficulty of maintaining donor thymic epithelial cells (TECs) in vitro to allow successful bioengineering. Here, we show that 3-D scaffolds generated from decellularized mouse thymus can support TEC survival in culture, and maintain their unique molecular properties. When transplanted into athymic nude mice, the bioengineered thymus organoids effectively promoted homing of lymphocyte progenitors and supported thymopoiesis. Nude mice transplanted with thymus organoids promptly rejected skin allografts, and were able to mount antigen-specific humoral responses against ovalbumin upon immunization. Notably, tolerance to skin allografts was achieved by transplanting thymus organoids constructed with either TECs co-expressing both syngeneic and 
Introduction
The primary function of the thymus is to continuously generate a diverse population of Tcells that can elicit adaptive immune responses against invading pathogens, while promoting self-tolerance [1] . The thymus is a rather vulnerable organ as many factors, including environmental insults, aging, genetic composition, virus infection, irradiation, and anti-cancer drug treatments, can all irreversibly compromise its function [2, 3] . Impaired immune surveillance consequent to thymic dysfunction leads to diseases ranging from autoimmunity to immunodeficiency and malignancy [4] .
The thymus is organized into two morphologically and functionally distinct compartments: the cortex and the medulla, which house two distinct populations of thymic epithelial cells (TECs): the cortical TECs (cTECs) and the medullary TECs (mTECs) [5] [6] [7] [8] .
Other thymic stromal cells (TSCs) include thymic fibroblasts, endothelial cells, as well as antigen presenting cells like macrophages and dendritic cells. Together, this network of thymic cells provides both homing signals for the immigration of lymphocyte progenitors originated from the bone marrow (BM), and trophic factors necessary for the differentiation and maturation of thymocytes [9] .
While numerous efforts have been made to correct thymic defects, manipulating the thymus, either in vitro or in vivo, proves to be challenging. This is mainly attributed to the unique architecture of the thymic stroma that is essential for the maturation, survival and function of TECs. Unlike epithelial cells of other visceral organs, which form a two-dimensional (2-D) sheet-like structure on the basement membrane to create borders within and between organs [10] , TECs form a sponge-like three dimensional (3-D) network that is essential for their function [11] . TECs cultured on irradiated 3T3 feeders (a 2-D environment) are unable to support T-cell differentiation from lymphocyte progenitors, but start to express markers of terminally differentiated epithelial cells [12] . Recently, TEC stem cells derived from early embryos were shown to differentiate into skin cells when cultured in 2-D environment [13] . Indeed, the expression of key genes for the specification and proliferation of TECs (e.g. FoxN1, DLL-4, CLL-22 and Tbata) are shown to be dependent on the 3-D organization of the thymic stroma, further indicating that the unique microenvironment of the thymus is essential to maintain the unique property of TECs to support T lymphopoiesis [14] .
Over the years, substantial progress has been made to reproduce the thymic microenvironment. Matrigel and other collagen-based synthetic matrices were shown to be able to support limited differentiation of lymphocyte progenitors into T-cells [15, 16] . TECs cultured in artificial 3-D matrix are viable and can partially support thymocyte development. Recently, Kyewski and colleagues developed a co-culture system, in which mTECs were layered on top of a 3-D artificial matrix embedded with human skin-derived dermal fibroblasts. Under such conditions, mTECs can retain some of their key features (e.g. expression of FoxN1, Aire and tissue-specific antigens) [17] . In a similar approach, Chung et al. mixed TECs and thymic mesenchyme, both isolated from postnatal human thymi, with CD34+ cells from cord blood to form implantable thymic units [18] . The thymic microenvironments of these thymic reaggregates can support thymopoiesis in vitro and are able to generate a complex T-cell repertoire when transplanted in NOD.scid gamma (NSG) humanized mice in vivo. However, to date, none of these approaches has been able to fully recapitulate the function of a thymus.
Recently, significant advances have been made in "cell-scaffold" technology [19] . This groundbreaking technology uses a detergent-perfusion based approach that allows the clearance of the cellular constituent of almost any organ of any scale, while retaining its original 3-D architecture and extracellular matrix (ECM) components [20, 21] . Repopulating the decellularized natural scaffolds with tissue-residing mature cells or progenitor/stem cells can promote its recellularization, and partially recover organ function [22] . To date, these "cellscaffolds" have been primarily applied to manufacture and implant relatively simple organs, such as tissue engineered vascular grafts and skin, with some success [23] [24] [25] . Regeneration of complex organs such as liver, heart, lung, and kidney has also been attempted in animal models [21, [26] [27] [28] [29] . While limited, encouraging functional regeneration of the engineered organs was observed. Furthermore, a successful clinical implantation of reconstructed decellularized trachea underlines the clinical potential of this technology [30] .
Here, we show that thymus organoids reconstructed with the "cell-scaffold" technology can support thymopoiesis in vivo to establish both humoral and cellular adaptive immunity in athymic nude mice. Additionally, they also induce central immune tolerance to allo-skin grafts.
Results

Bioengineering thymus organoids with decellularized thymus scaffolds.
To investigate the possibility of reconstructing viable thymus organoids with TECs, we developed a thymus decellularization protocol improvised from a previous approach described for embryoid bodies [22, 31, 32] . This allowed us to remove all the cellular elements of a mouse thymus, while maintaining all the major ECM components (Fig. 1a-1d ). Scanning electron microscopy (SEM) analysis of the cross-section images of the acellular thymic scaffolds revealed the preservation of ECM micro structures (e.g. grooves, ridges, and the fibrillar meshwork), indicating that the 3-D architecture of thymic stromal ECM is largely intact following the decellularizing treatment (Fig. 1e) . Supplementary   Fig. S1a ), were harvested from 3-4 weeks old mice and were injected into the decellularized scaffolds and cultured in the top chamber of transwells. Since previous studies have shown that cross talk between TECs and the developing thymocytes are essential for their mutual survival and proliferation [2] , lineage marker negative (Lin -) progenitor cells from BM were cointroduced into the thymus scaffolds to mimic the immigration of lymphocyte progenitors (Fig.   2a , and Supplementary Fig. S1b -S1c) . In striking contrast to the rapid loss of adult TSCs in hanging drop culture, or in porous disc on a gel foam routinely used for in vitro fetal organ cultures, TSCs remained viable for more than 3 weeks in the 3D-thymic scaffolds (Fig. 2b-2c and Supplementary video SV1-2). Of note, 7 days after thymus reconstruction, some of the injected stromal cells began to assume a fibroblast-like morphology, suggesting that these cells successfully colonized the 3D ECM (Fig. 2b) . Immunohistochemical analysis of reconstructed thymus organoids cultured in vitro showed the presence of both TECs and CD45 + lymphoid cells that there exist progenitor cells of the thymic epithelia in the adult thymus [33] . In addition, other thymic stromal cells, such as CD31+ endothelial cells and thymic fibroblasts were also present, suggesting that the 3-D scaffold microenvironment is suitable for the survival of various TSC types (Fig. 2d) .
CD45-TSCs, including TECs, endothelial cells and thymic fibroblasts (
Under 2-D culture conditions, TECs rapidly lose their signature gene expression and upregulate the expression of markers of terminally differentiated skin epithelial cells [17] .
Simultaneously, they also lose their capability to positively and negatively select developing thymocytes. In contrast, transcription of TEC-specific genes was readily detectable in the reconstructed thymus organoids cultured for 7-days in vitro (Fig. 2e) . These included the widely used thymic epithelium marker EpCAM, and the transcription factor Foxn1, which regulates the expression of a number of key factors in TECs (e.g. Dll4) that are essential for thymopoiesis.
Transcripts of Ccl25, a downstream target of Foxn1 that promote the homing of hematopietic progenitors in the thymus, were also present in the thymus organoids [34] . In addition, both Krt5
and Krt8, the cytokeratins predominantly present in mTECs and cTECs, respectively, were expressed, suggesting that both cTECs and mTECs were present. Interestingly, factors that can modulate TEC proliferation (e.g. Trp63 and Tbata) were also expressed in cells of the bioengineered thymus.
Another signature feature of mTECs is their capability to ectopically express tissue specific antigens (TSAs), believed to be a key part of the central mechanism to distinguish self from non-self and establish immune tolerance to peripheral tissues and organs [35, 36] . mRNA transcripts of Aire, one of the key regulators of thymic TSA expression, were present in TSCs of the thymus organoids, in conjunction with both Aire-dependent (e.g. Ins2) [32] and Aireindependent (e.g. Ica1) [37] TSAs (Fig. 2f) . The persistence of TEC marker expression in the thymus organoids after extensive in vitro culture (Fig. 2f) Supplementary Fig. 3 ). Taken Fig. S5 ). To further assess the diversity of T-cells generated from the reconstructed thymus organoids, we performed next-generation-sequencing-spectratyping (NGS-S) analysis, which employs high coverage Roche/454 sequencing of TCR ( )-chain amplicons [43] . Broad spectra of V gene families were observed, suggesting that the T-cell repertoire was quite diverse ( Fig. 3d and Supplementary Fig. S6 ). Notably, more than 99 % of the T-cells were CD45.1
The bioengineered thymus can support T lymphopoiesis in vivo
indicating their recipient origin (Fig. 3e) . Taken together, these results suggested that the bioengineered thymus organoid constructed from adult TSCs could effectively attract the homing of lymphocyte progenitors from the recipient's BM, and supported the development of a diverse T-cell repertoire.
The majority of the CD8+ T lymphocytes in the spleens of Tot.B6.nude mice displayed a CD62L high CD69 low phenotype, suggesting that they were naïve cells, whereas the percentages of CD4+ T-cells with activated phenotype was higher than naïve B6 mice ( Fig. 3f ). This might be the natural response of newly generated T-cells under lymphopenic conditions [44] .
Nevertheless, none of the thymus-reconstructed mice displayed any pathological sign of autoimmunity, nor did we observe any lymphocytic infiltration in various solid organs with histology analysis (e.g., liver, pancreas and heart, etc. Data not shown). The percentages of regulatory T-cells (Treg) in the spleens of transplanted nude mice were similar to those of naïve B6 controls (Fig. 3g) , consistent with a self-tolerant T-cell repertoire. Furthermore, the CD4+CD25+Foxp3+ Tregs were predominantly positive for Helios, a marker for naturally occurring Treg subset [45] , suggesting that they most likely originated from the transplanted thymus organoids (Fig. 3h ).
Immunohistochemical examination of the thymus organoid grafts 16-weeks posttransplantation showed the presence of EpCAM+ TECs, as well as CD4+ and/or CD8+ thymocytes underneath the kidney capsules (Fig. 3i) . These results further suggested that the thymus organoid grafts can support the survival and function of the TECs, but also promote the homing and differentiation of lymphocyte progenitors in vivo.
Effective cellular and humoral adaptive immunity mediated by T-cells matured in bioengineered thymus organoids
Proliferation under various stimuli has been widely used as a tool to assess the To demonstrate that T-cells derived from the bioengineered thymus can effectively mediate cellular immune response in vivo, we performed allo-skin transplantation experiments, to examine whether the recipients can reject skin allografts. Allogeneic skin grafts harvested from CBA/J mice (H-2 k ) were transplanted to the back of Tot.B6.nude mice (n=3). Syngeneic skin grafts from B6 mice (H-2 b ) were co-transplanted as controls. While the syngeneic skin grafts were well tolerated, the allogeneic skins were rejected within 2-3 weeks, with kinetics similar to naïve B6 recipient controls (n=4) (Fig. 4c ). In contrast, allogeneic skin grafts on B6.nude mice that had been transplanted with decellularized empty scaffolds were viable for more than 8-weeks ( congenic mice were transplanted on their backs. To demonstrate that the thymus organoid transplanted recipients retained their capabilities to reject third party alloantigens, skin grafts harvested from CBA/J (H-2 k ) mice were also transplanted (Fig. 5a ). Successful engraftments of skin transplants from both the syngeneic B6 and the allogeneic B6.H-2 g7 mice were observed, whereas the third party CBA/J skin grafts were rejected within 2-3 weeks ( Fig. 5b and 5c ).
Immune unresponsiveness to H-2 g7 alloantigens in the recipients was further demonstrated in MLR assays (Fig. 5d ). Taken together, these results suggested that transplantation of bioengineered thymus organoids co-expressing both syngeneic and allogeneic MHCs can effectively establish donor-specific immune tolerance.
Induction of allo-skin tolerance with bioengineered thymus organoids constructed with mixture of TECs from both the donor and the recipient.
While reconstructing thymus organoids with TECs co-expressing both donor-and recipient-MHCs can effectively induce tolerance to donor MHC-expressing grafts, it is not clinically feasible to transfer donor MHC genes to the recipient's TECs at such high efficiency (100% in the case of F1 TECs), using currently available gene engineering techniques.
Moreover, epitopes derived from mismatched genes other than the MHCs in the allogeneic donor organ(s) can also contribute to its rejection. One possible way to overcome these obstacles is to incorporate the donor TECs in the thymus organoids, together with the recipient's TECs. To test this hypothesis, we performed the experiments schematically illustrated in Figure 6a . TECs harvested from B6 (H-2 b ) and CBA/J (H-2 k ) were mixed at 1:1 ratio and co-injected with B6 BM progenitors to the decellularized thymus scaffolds. B6.nude mice reconstructed with the thymus organoids were challenged with allogeneic CBA/J skins, as well as skin grafts from the third party Balb/C mice (H-2 d ). Prolonged survival of the CBA/J skin allografts was observed (Fig.   6b ). Consistently, results of MLR experiments revealed that when challenged with CBA/J APCs, the levels of T-cell proliferation were significant lower than those stimulated with Balb/C APCs.
These findings further suggested that including donor TECs in the reconstruction of thymus organoids might be a clinical applicable means to induce donor-specific immune tolerance.
Discussion
We provided functional evidence that bioengineered thymus organoids made of decellularized thymic scaffolds populated with TECs and Lin -BM progenitors, can re-assert thymic T-cell generation in athymic nude mice. While attempts to decellularize the thymus glands and repopulate them with epithelial cells have been reported previously [46, 47] , to our Second, the engraftment site (i.e. kidney capsules) might not be optimal for the survival and function of the thymus organoids. In our studies, intact thymi of 2-week old mice had largely degenerated 2-4 weeks after transplantation underneath the kidney capsules (data not shown).
One of the major obstacles might be the inefficiency of angiogenesis. To promote graft vascularization, Seach et al. embedded thymus fragments in housing chambers consisting of silicone tubing and implanted the device in the vicinity of epigastric blood vessels of nude mice [54] . While limited, successful T-cell development was observed, and mice were able to reject MHC miss-matched skin grafts. Recently, Chung and colleagues co-cultured human postnatal
TECs and thymic mesenchymal cells that were transduced with vascular endothelial growth factor (VEGF)-expressing lentiviral vectors, and showed that the engineered human thymic aggregates can support thymopoiesis both in vitro and in vivo [18] . Refining our thymus bioengineering protocol with these angiogenesis-promoting techniques might enable us to improve survival and the efficacy of the transplanted thymus organoids to support T lymphopoiesis.
To closely mimic the clinical situation, we did not use 16-day prenatal mouse embryos to obtain TSCs, but harvested them from 2-4 week old young mice. While it was previously demonstrated that a single stem cell from the embryonal region of the thymus can recapitulate the developmental process of the whole thymus organ, and TEC stem cell lines with the potency to differentiate into various TEC subsets have been isolated from 16-day prenatal embryos, the presence and prevalence of multipotent TEC progenitors in a postnatal thymus remains a matter of debate. Consistently, the levels of T-cell development in nude mice transplanted with bioengineered thymus organoids were similar to those transplanted with intact, thymocytedepleted thymi of 2-4 week old mice. Thus, the low T-cell numbers in the thymus-transferred nude mice might reflect the intrinsic limitation of the postnatal thymus to fully reconstruct the Tcell repertoire. TECs [55] [56] [57] [58] . Recent studies showed that forced expression of the TEC-specific transcription factor FoxN1 could rejuvenate the involuted thymus and increase naïve T cell output in aged mice, suggesting the feasibility of prolonging the function of adult TECs by genetically modulating the expression of key lineage-determining factors in TEC biology [59, 60] .
Alternatively, donor TECs can be generated from embryonic stem cells (ESCs) [61, 62] , induced pluripotent stem cells (iPSCs) [63] , or genetically reprogrammed embryonic fibroblasts [64] .
Aided by advances in targeted gene delivery technologies [65, 66] , we might be able to fine-tune the antigen presentation properties of TECs and bioengineer individualized thymus organoids to achieve long-term donor-specific immune unresponsiveness in clinical transplantation, or to regain self-tolerance to specific tissues in treating autoimmune disorders with known major autoantigen(s). At present, thymus scaffolds can be prepared from thymus glands harvested from cadavers or patients undergoing cardiothoracic surgery in which the thymic samples are removed as waste tissue. As shown in our study, scaffolds prepared from mouse thymi can be stored at 4 o C for up to one month before use; it is likely that human thymus scaffolds can be preserved in a similar fashion. Since there is no cellular component in the decellularized thymus scaffold, we believe that allogeneic (or even xenogeneic) rejection won't be a concern. The thymus organoid can be reconstructed with TECs harvested from the donor and a properly preserved decellularized thymus scaffold from a third party. Indeed, even with the current technology, our preliminary experiments suggest that this thymus bioengineering approach is applicable to nonhuman primates (Fan et al., unpublished observations). were obtained from both nude mouse strains.
Materials and methods
Mice
Skin Transplantation
Tail-skin graft was excised from euthanized donor mouse (about 1 cm long and 0.5 cm wide), and was placed on a bed prepared by removing an area on the back dermis of the either B6.nude or Tot.B6.nude recipient. The graft was sutured, covered with gauze, and was wrapped with sterile bandage. Skin graft survival was monitored daily and rejection was defined as graft necrosis of more than 80%.
Decellularization of mouse thymus
Decellularization was carried out by chemical detergent washing similar to previous study [22, 31] . Briefly, thymi of 3-4 week old mice were stored in -80°c until decellularization was initiated. Thymi were thawed in a 37°C water bath. This free-thaw process was repeated three times. Next, ionic detergent, 0.1% SDS (Invitrogen) in deionized water was added to the thymi and placed on a 3-D rotator (Lab Line, Thermo Scientific) for continuous rotation until the tissues became translucent and white in color (24 hours). Thymi were subsequently washed in PBS for three times, each for 15 minutes, followed by 30 minutes in 1% Triton X-100 (Sigma Aldrich). This was followed by three more PBS washes. A final wash step of PBS with Pen/Strep (100U/ml) was added and the scaffolds were rotated for additional 48 hours. The decellularized thymus scaffolds were stored in PBS at 4ºC for up to a month, and were switched to RPMI-10 culture medium (RPMI-1640 with 10% fetal bovine serum (FBS), 100 U/mL Penicillin, 100 ug/mL Streptomycin, 2mM L-glutamine, 10mM HEPES) 24 hours before use.
Thymus Organoid Reconstruction
To reconstruct the thymus organoids, thymic tissue was harvested from 2-3 week old B6 mice, unless specified otherwise, and separated into single cells with collagenase digestion as previously described [32, 67] . In brief, thymic tissue (n=3-4) was pooled and needle dissected T-cell depleted, mitomycin C (Sigma) treated splenocytes harvested from CBA/J mice, added to wells of 96-well plates, and cultured for 4-7 days. Cells were labeled as described above for FCM analyses. In addition, cells were stained with anti-H2-K k and anti-H2-K b antibodies to label the stimulator (CBA/J) and responder (Tot.B6.nude) populations, respectively. Unless specified otherwise, all the experiments were run in triplicate and repeated at least three times.
Histology and Immunohistochemistry
Reconstructed thymus organoids and kidneys were fixed in 4% paraformaldehyde for 3 h 
ELISPOT analysis
ELISPOT was performed using the BD mouse IFN-γ set (BD Biosciences), as previously described [70] . Briefly, splenocytes were isolated from OVA peptide immunized Tot.B6.nude (n=4), or B6 controls (n=4), suspended at 4.5x10 6 /ml concentration in RMPI-10, and cultured for 24 hours at 37 o C, in the presence of 50µg/ml OVA peptides (AVHAAHAEINEAGSIINFEKL).
Unattached cells were harvested, washed, counted and resuspended at 3x10 6 cells/ml in RPMI-10, supplemented with 50µg/ml OVA peptides. In some experiments, TSCs were first labeled with carboxyfluorescein diacetate, succinimidyl ester (CFSE) before being injected into the acellular thymus scaffolds. The presence and distribution of CFSE+ cells in the reconstructed thymus organoids cultured in vitro were followed under the fluorescence microscope for up to 4-weeks.
RNA analysis
Total RNA was extracted from 250,000 TSCs and reconstructed thymus organoids cultured in vitro with RNeasy micro kit, according to the manufacturer's protocol (Qiagen).
Following DNase I treatment (Ambion), RNA samples were reverse-transcribed into cDNAs with Superscript III cDNA kit, with random hexamers as primers for the RT reaction (Invitrogen). Semi-quantitative PCR was performed as previously described [71] . cDNA samples were diluted serially (1:5) and equal volumes of dilutents were used as templates for PCR 
Scanning Electron Microscopy (SEM)
Native and decellularized thymi were fixed in 2.5% glutaraldehyde in 0.1 M PBS (pH 7.4) for 60 min. The samples were washed thoroughly in 3 changes 0.1 M PBS for 15 min each.
Next, the samples were fixed in 1% OsO4 in 0.1 M PBS for 60 min. This was followed by another 3 changes of PBS washing steps for 15 min each. The samples were then dehydrated in gradient series of alcohol for 15 min each. Additionally, samples were critical point dried and coated with Au/Pd using a Cressington Coater 108A sputter coater. Electron microscope images were taken using a Jeol JSM-6335F field emission SEM.
Statistical analysis.
All values are expressed as the mean ± SEM unless otherwise specified. In mouse studies, statistical significance was determined using nonparametric Mann-Whitney test. All statistical analyses were carried out with the GraphPad Prism 4.0 Software. In all experiments, differences were considered significant when p was less than 0.05. financial interests. Fig. S1 .
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